Clinical trial

Effects of Interleukin-6 Inhibition on Vascular, Endothelial and Left Ventricular Function in Rheumatoid Arthritis

NCT03288584

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Tocilizumab (Actemra®) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Other biological agent Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Corticosteroid and non-biological agents. Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of Interleukin-6 Inhibition on Vascular, Endothelial and Left Ventricular Function in Rheumatoid Arthritis

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2017-10-27

PhaseN/A

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Inflammationunresolved

Interventions

Tocilizumab (Actemra®)DRUG

Other biological agentDRUG

Corticosteroid and non-biological agents.DRUG

Sponsors & collaborators

University of Athenslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03288584 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.